Azienda Ospedaliera Universitaria S. M. Misericordia Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2013
NCT01791101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Clinica Ematologica, DISM, Azienda Ospedaliera Universitaria S. M. Misericordia

Active Ingredients

Drugs in Phase 2 Trials (1)

eltrombopag (promacta) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Purpura, Thrombocytopenic, Idiopathic (Phase 2)

Thrombocytopenia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1